NBIX
Neurocrine Biosciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$155.64
−1.71%Leverage
- Debt / equity
- 0.11x
- Net debt / equity
- 0.02x
- Debt / assets
- 0.07x
- Debt / EBITDA
- 0.44x
- Net debt / EBITDA
- 0.08x
Liquidity & coverage
- Current ratio
- 1.87x
- Quick ratio
- 1.75x
- Cash ratio
- 0.45x
- Interest coverage
- 272.03x
- EBITDA / interest
- 316.59x
- Working capital
- $763.0M
Cash & dividend
- FCF / debt
- 2.17x
- Cash flow / debt
- 2.24x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026